Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$307M |
| 2 |
Vanguard Morningstar Value ETF
VTV
|
+$294M |
| 3 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$246M |
| 4 |
Costco
COST
|
+$225M |
| 5 |
Lyft
LYFT
|
+$223M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ferguson
FERG
|
+$692M |
| 2 |
Linde
LIN
|
+$624M |
| 3 |
Medtronic
MDT
|
+$527M |
| 4 |
Goldman Sachs
GS
|
+$340M |
| 5 |
Microsoft
MSFT
|
+$301M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.25% |
| 2 | Healthcare | 13.3% |
| 3 | Financials | 12.53% |
| 4 | Consumer Discretionary | 10.81% |
| 5 | Communication Services | 8.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
INDT
3401
DELISTED
INDUS Realty Trust, Inc. (MD) Common Stock
INDT
| $967K | ﹤0.01% |
14,739
+1,752
| +13% | +$112K |
|
3402
Zedge
ZDGE
$38.4M
| $965K | ﹤0.01% |
52,402
+25,543
| +95% | +$357K |
|
|
ICAD
3403
DELISTED
iCAD Inc
ICAD
| $952K | ﹤0.01% |
54,999
+2,614
| +5% | +$45.9K |
|
3404
KALA BIO
KALA
$18.3M
| $950K | ﹤0.01% |
72
+4
| +6% | +$62.9K |
|
|
KNTE
3405
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
| $948K | ﹤0.01% |
40,723
+4,957
| +14% | +$126K |
|
|
ATHX
3406
DELISTED
Athersys, Inc. Common Stock
ATHX
| $946K | ﹤0.01% |
26,271
-2,554
| -9% | -$105K |
|
|
AKUS
3407
DELISTED
Akouos Inc
AKUS
| $945K | ﹤0.01% |
75,305
+6,277
| +9% | +$85.1K |
|
3408
ORIX
IX
$43.6B
| $944K | ﹤0.01% |
55,725
+11,870
| +27% | +$203K |
|
|
PFHD
3409
DELISTED
Professional Holding Corp. Class A Common stock
PFHD
| $943K | ﹤0.01% |
52,340
-29,269
| -36% | -$523K |
|
3410
NACCO Industries
NC
$322M
| $941K | ﹤0.01% |
36,160
-11,770
| -25% | -$293K |
|
3411
Rekor Systems
REKR
$98.2M
| $940K | ﹤0.01% |
92,509
+77,352
| +510% | +$1.19M |
|
3412
Hurco Companies Inc
HURC
$146M
| $939K | ﹤0.01% |
26,812
-9,933
| -27% | -$346K |
|
|
LITS
3413
Lite Strategy Inc
LITS
$30.2M
| $939K | ﹤0.01% |
16,475
-1,320
| -7% | -$84.8K |
|
|
TLIS
3414
DELISTED
Talis Biomedical Corporation Common Stock
TLIS
| $938K | ﹤0.01% |
5,666
+337
| +6% | +$57.2K |
|
3415
Atlanta Braves Holdings Series A
BATRA
$3.68B
| $934K | ﹤0.01% |
33,084
-3,150
| -9% | -$87.8K |
|
3416
Zevra Therapeutics
ZVRA
$672M
| $931K | ﹤0.01% |
+72,645
| New | +$781K |
|
|
ESTE
3417
DELISTED
Earthstone Energy Inc. Class A Common Stock
ESTE
| $931K | ﹤0.01% |
84,063
-1,996
| -2% | -$18.1K |
|
3418
Spero Therapeutics
SPRO
$71.2M
| $930K | ﹤0.01% |
66,595
+3,423
| +5% | +$47.8K |
|
3419
iShares MSCI Philippines ETF
EPHE
$146M
| $929K | ﹤0.01% |
30,031
-6,843
| -19% | -$205K |
|
3420
Forte Biosciences
FBRX
$1.57B
| $928K | ﹤0.01% |
+1,104
| New | +$995K |
|
3421
Citizens
CIA
$201M
| $927K | ﹤0.01% |
175,283
-12,397
| -7% | -$68.3K |
|
|
QTNT
3422
DELISTED
Quotient Limited Ordinary Shares
QTNT
| $927K | ﹤0.01% |
6,365
-610
| -9% | -$97.5K |
|
3423
Aligos Therapeutics
ALGS
$43M
| $926K | ﹤0.01% |
1,817
+546
| +43% | +$348K |
|
3424
Aterian
ATER
$5.44M
| $925K | ﹤0.01% |
+5,268
| New | +$1.23M |
|
3425
iBio
IBIO
$71M
| $922K | ﹤0.01% |
1,222
+200
| +20% | +$146K |
|
Similar funds
Bank of New York Mellon's Q2 2021 Portfolio in Review
As of Q2 2021, Bank of New York Mellon held 4,590 positions worth $517B, up 5.6% from $489B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Bank of New York Mellon's Q2 2021 filing shows 277 new, 1,772 increased, 2,129 reduced and 201 closed positions. Its largest new stake was Organon & Co: 4,240,135 shares worth $128M. The largest sale was Ferguson, an estimated $692M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.
- Bank of New York Mellon's largest Q2 2021 buy was Organon & Co: 4,240,135 shares worth $128M.
- Bank of New York Mellon added most to Vanguard FTSE Developed Markets ETF in Q2 2021, an estimated $307M increase.
- Bank of New York Mellon's biggest Q2 2021 reduction was Ferguson, cutting an estimated $692M.
- Bank of New York Mellon fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $164M.
- Bank of New York Mellon's ten largest holdings make up 19% of its $517B portfolio in Q2 2021.
- Bank of New York Mellon opened 277 new positions and closed 201 in Q2 2021.
- Bank of New York Mellon's portfolio value rose 5.6% quarter-over-quarter to $517B.
Based on Bank of New York Mellon's 13F filing for Q2 2021, filed 11 Aug 2021.